EFNB2 and neoplasm: In this study, we developed a novel angiogenesis score and feature genes (MMRN2, CLEC14A, ACVRL1, EFNB2, and TEK) which was associated with tumor angiogenesis microenvironment and prognosis in KIRC patients.